The, Chair

The Chair Is Not the Cure: What Two Decades of Ergonomics Research Actually Shows

Published on 11/03/2026 at 07:41 | Editorial boerse-global.de
A Cochrane review of 20 trials with 2,478 workers found adjustable desks and lumbar supports made little difference to pain, recovery or sick leave.
The Chair Is Not the Cure: What Two Decades of Ergonomics Research Actually Shows Illustration mit AI erstellt.

Twenty randomised trials, 2,478 office workers and a verdict that undercuts the office-furniture industry: adjustable desks and lumbar cushions barely move the needle on pain, recovery or sick leave.

Back pain will find most of us eventually. Roughly 80 percent of people experience it at some point in their lives, and the World Health Organization notes that about 90 percent of lower-back cases are non-specific — which is why medication is not recommended as a first-line response.

The economic footprint is heavy. A 2020 study involving Canada's Conestoga College put the productivity losses from musculoskeletal disorders to the country's economy at almost CAD 15 billion. In Quebec alone, some 2.5 million working days were lost to these conditions in 2022. Faulty movement patterns, repetitive strain and lifting heavy loads without using the legs all add stress to the lumbar spine.

A Cochrane Review Cools Expectations

Against that burden, ergonomic office furniture is widely marketed as a fix. Systematic evidence suggests otherwise. A Cochrane review led by researchers from the University of Technology Sydney and the University of Sydney, working with specialists from the Netherlands, Denmark and the United Kingdom, examined 20 randomised controlled trials covering 2,478 workers with complaints in the arm, neck and shoulder.

Its finding: ergonomic adjustments — height-adjustable desks, ergonomic office chairs, lumbar supports or biomechanical instruction — made little or no measurable difference to pain relief, recovery or sick leave compared with no intervention at all.

The numbers behind that conclusion break down across subgroups. Among 692 participants, no difference in pain emerged; 386 subjects showed barely any difference in recovery, and 68 participants showed little difference in quality of life. Low-certainty data hinted at only minimal benefits for rotator cuff syndrome. Lead author Poonam Mehta called for further high-quality studies as a result.

Sitting Still Is the Real Problem

Occupational physicians draw a practical lesson from all this: avoid rigid postures and keep the working day moving. Figures from EU-OSHA show that sitting upright without support raises pressure on the lumbar discs to 140 percent of the level measured while standing; leaning the upper body forward pushes that figure to 190 percent.

The agency's guidance is to spend no more than half the working day seated, take short breaks every 20 to 30 minutes, and after two hours stand or walk for at least ten minutes. One physiotherapist recommends the 25/50/25 rule — per hour, 15 minutes standing, 30 minutes sitting and 15 minutes in motion. Prolonged standing carries its own risks, according to a University of Sydney study, including varicose veins and circulatory problems.

Movement Beats Furniture

For prevention, researchers point to activity rather than equipment. A Macquarie University study found that a regular 30-minute walk eases back pain, and current research treats roughly 7,000 steps a day as a benchmark for general fitness.

Concrete specifications for workstation design come from specialist portals. The education portal edu.rs gives an average height of 1,125 millimetres for sit-stand desks and a work surface of 800 to 1,150 millimetres. For seated writing it cites a table height of 70 to 76 centimetres, and 66 to 71 centimetres for keyboard use, with 70 centimetres regarded as the optimal baseline for average body sizes.

Consultancies such as Cubus GmbH split workplace design into five structured steps — room analysis, seating position, screen alignment, and lighting and acoustics planning — to tailor environments holistically to human needs.

Disclaimer...
en | boerse | 70449016 |